This article has been corrected. See "Corrigendum: Amniotic Fluid Embolism: Maternal Disseminated Intravascular Coagulation, Cardiovascular Collapse, and Acute Hypoxic Cases Shortly after Delivery" in Volume 30 on page 260.
Abstract
Amniotic fluid embolism (AFE) is a fatal disease in only pregnant woman during labor and delivery. The pathologic findings that have demonstrated fetal squamous cells in the pulmonary circulation are no more specific. Then, clinically characteristic signs and symptoms, such as cardiovascular collapse, acute hypoxia, disseminated intravascular coagulation, mental change and laboratory findings are the key points for diagnosis. Having a doubt on those sign and symptoms is the beginning of diagnosis and promptly multidisciplinary management is required. Korean National Registry for AFE must be established and we have to find out the diagnostic criteria, possible etiology, pathophysiology, management and treatment for AFE.
REFERENCES
1). Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@ smfm.org, Pacheco LD, Saade G, Hankins GD, Clark SL. Amniotic fluid embolism: diagnosis and management. Am J Obstet Gynecol. 2016. 215:B16–24.
2). Shamshirsaz AA., Clark SL. Amniotic fluid embolism. Obstet Gynecol Clin North Am. 2016. 43:779–90.
3). Meyer JR. Embolia pulmonary amnio caseosa. J Bras Med. 1926. 2:301–3.
4). Steiner PE., Lushbaugh CC. Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA. 1941. 117:1245–54.
5). Liban E., Raz S. A clinicopathologic study of fourteen cases of amniotic fluid embolism. Am J Clin Pathol. 1969. 51:477–86.
6). Steiner PE., Lushbaugh CC. Landmark article, Oct. 1941: Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. By Paul E. Steiner and C. C. Lushbaugh. JAMA. 1986. 255:2187–203.
7). Clark SL. New concepts of amniotic fluid embolism: a review. Obstet Gynecol Surv. 1990. 45:360–8.
8). Belfort M., Saade G., Foley M., Phelan J., Dildy G. Critical care obstetrics. 5th ed. Oxford: Wiley-Blackwell, 2010, p. 466–74.
9). Clark SL., Paylova Z., Greenspoon J., Horenstein J., Phelan JP. Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol. 1986. 154:104–6.
10). Lau G. Amniotic fluid embolism as a cause of sudden maternal death. Med Sci Law. 1994. 34:213–20.
12). Romero R., Kadar N., Vaisbuch E., Hassan SS. Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection? Am J Reprod Immunol. 2010. 64:113–25.
13). Conde-Agudelo A., Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol. 2009. 201:445. .e1-13.
14). Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypotheses. 2007. 68:1019–25.
15). James CF., Feinglass NG., Menke DM., Grinton SF., Papadimos TJ. Massive amniotic fluid embolism: diagnosis aided by emergency transesophageal echocardiography. Int J Obstet Anesth. 2004. 13:279–83.
16). Clark SL., Hankins GD., Dudley DA., Dildy GA., Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995. 172:1158–67.
17). Kim BI., Paek SH., Rho WS., Lee SP., Cho SK., Lee SH. Amniotic fluid embolism during dilatation and curettage in a second trimesteric missed aborted pregnant patient. Korean J Anesthesiol. 1997. 33:778–83.
18). Clark SL., Romero R., Dildy GA., Callaghan WM., Smiley RM., Bracey AW, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2016. 215:408–12.
19). Tanaka H., Katsuragi S., Osato K., Hasegawa J., Nakata M., Murakoshi T, et al. Value of fibrinogen in cases of maternal death related to amniotic fluid embolism. J Matern Fetal Neonatal Med. 2017. 30:2940–3.
20). Rath WH., Hofer S., Sinicina I. Amniotic fluid embolism: an interdisciplinary challenge: epidemiology, diagnosis and treatment. Dtsch Arztebl Int. 2014. 111:126–32.
21). Matsuda Y., Kamitomo M. Amniotic fluid embolism: a comparison between patients who survived and those who died. J Int Med Res. 2009. 37:1515–21.
22). Leighton BL., Wall MH., Lockhart EM., Phillips LE., Zatta AJ. Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports. Anesthesiology. 2011. 115:1201–8.
23). Clark SL. Successful pregnancy outcomes after amniotic fluid embolism. Am J Obstet Gynecol. 1992. 167:511–2.
24). Stiller RJ., Siddiqui D., Laifer SA., Tiakowski RL., Whetham JC. Successful pregnancy after suspected anaphylactoid syndrome of pregnancy (amniotic fluid embolus). A case report. J Reprod Med. 2000. 45:1007–9.
25). Kim JI., Kim TH., Park KG. A case of amniotic fluid embolism: detection by postmortem autopsy. Korean J Perinatol. 1994. 5:363–67.
26). Kim JY., Yang JI., Ryu HS., Oh KS., Joo HJ. A case of amniotic fluid embolism in cervical vessels after delivery. Korean J Obstet Gynecol. 1997. 40:1528–31.
27). Park CW., Kim SS., Han SY., Ko EM., Shim SS., Cheon DW, et al. A case of amniotic fluid embolism during the labor. Korean J Obstet Gynecol. 2002. 45:864–8.
28). Kim SY., Kang BS., Park CM. A case of intrapartum amniotic fluid embolism with seizure. Korean J Obstet Gynecol. 2006. 49:2199–203.
Table 1.
125 | 226 | 317 | 427 | 528 | 629 | |
---|---|---|---|---|---|---|
Presented at | 1994, Perinatology | 1997, KJOG | 1997, KJA | 2002, KJOG | 2006, KJOG | 2010, KJA |
Method of diagnosis | Autopsy∗ | Histopathological test at uterine cervical vessel | Clinical symptoms, blood test† | Clinical symptoms | Clinical symptoms | Clinical symptoms, autopsy |
Age (year) | 34 | 27 | 30 | 42 | 36 | 33 |
Gravida | Primigravida | Multigravida | Multigravida | Primigravida | Multigravida | Primigravida |
GA (weeks) | 40 | 38 | 15+2 | 40+6 | 39+3 | 40 |
IOL | Yes | - | - | Yes, oxytocin | Yes, oxytocin | Yes, oxytocin |
Delivery method | Vaginal | Vaginal | Dilatation & curettage | Did not delivery | Vaginal | Cesarean section |
Time of initiation | 2 hours after delivery | Just after delivery | 28 minutes after procedure | Simultaneous with fetal distress | Simultaneous with fetal distress | 5 minutes after spinal anesthesia |
Initial sign and symptoms | Postpartum bleeding, irritability, semicoma | Postpartum bleeding, shock | Cyanosis, hypotension | Fetal distress, maternal cyanosis, hypotension | Fetal distress, seizure, loss of consciousness | Maternal respiratory distress, coughing, hypotension |
Clinical sign and symptoms | Postpartum bleeding, irritability, semicoma, hypotension | Postpartum atony bleeding | Cyanosis, hypotension, loss of cons | Respiratory arrest, cardiac arrest ciousness, DIC | Fetal distress, coma, hypotension | Respiratory distress, hypotension, profuse tracheal discharge |
Prognosis | Death within 6 hours after delivery | Improved | Hypoxic brain damage, motor disability | Death within 2 hours after initial symptoms | Death within 5 hours after initial symptoms | Death within 3 hours after initial symptoms |
Table 2.
Table 3.
Time of initiation | During labor, delivery, and cesarean section. At least within 2 hours after delivery. Do not over 24 hours after delivery. |
Clinical sign and symptoms | Acute hypotension∗, cardiac arrest, acute hypoxia∗, DIC∗, Loss of consciousness, seizure, heavy bleeding∗. |
Differential diagnosis | Pulmonary thromboembolism, transfusion complications, ischemic heart disease, anaphylactic shock, septic shock, perinatal cardiomyopathy, air embolism, high level spinal anesthesia, uterine rupture, uterine atony, reproductive tract laceration, postpartum heavy bleeding, acute fatty liver, severe preeclampsia, eclampsia, medical problems of heart, lung, and hematologic parts. |
Do not include histopathological test for fetal origin squamous cells at pulmonary and uterine vessels. |